Works matching IS 00912700 AND DT 2013 AND VI 53 AND IP 10

Results: 13

Population pharmacokinetics of empagliflozin, a sodium glucose cotransporter 2 inhibitor, in patients with type 2 diabetes.

Published in:

Journal of Clinical Pharmacology, 2013, v. 53, n. 10, p. 1028, doi. 10.1002/jcph.147

By:

Riggs, Matthew M.;
Staab, Alexander;
Seman, Leo;
MacGregor, Thomas R.;
Bergsma, Timothy T.;
Gastonguay, Marc R.;
Macha, Sreeraj

Publication type:

Article

A model-based approach to characterize the population pharmacokinetics and the relationship between the pharmacokinetic and safety profiles of RBP-7000, a new, long-acting, sustained-released formulation of risperidone.

Published in:

Journal of Clinical Pharmacology, 2013, v. 53, n. 10, p. 1010, doi. 10.1002/jcph.141

By:

Gomeni, R.;
Heidbreder, C.;
Fudala, P.J.;
Nasser, A.F.

Publication type:

Article

An integrated clinical pharmacology approach for deriving dosing recommendations in a regulatory setting: Review of recent cases in psychiatry drugs.

Published in:

Journal of Clinical Pharmacology, 2013, v. 53, n. 10, p. 1005, doi. 10.1002/jcph.118

By:

Younis, Islam R.;
Rogers, Hobart;
Zhang, Huixia;
Zhu, Hao;
Uppoor, Ramana S.;
Mehta, Mehul U.

Publication type:

Article

Investigation of an alternative generic model for predicting pharmacokinetic changes during physiological stress.

Published in:

Journal of Clinical Pharmacology, 2013, v. 53, n. 10, p. 1048, doi. 10.1002/jcph.131

By:

Peng, Henry T.;
Edginton, Andrea N.;
Cheung, Bob

Publication type:

Article

Sex differences in cyclosporine pharmacokinetics and ABCB1 gene expression in mononuclear blood cells in African American and Caucasian renal transplant recipients.

Published in:

Journal of Clinical Pharmacology, 2013, v. 53, n. 10, p. 1039, doi. 10.1002/jcph.123

By:

Tornatore, Kathleen M.;
Brazeau, Daniel;
Dole, Kiran;
Danison, Ryan;
Wilding, Gregory;
Leca, Nicolae;
Gundroo, Aijaz;
Gillis, Kathryn;
Zack, Julia;
DiFrancesco, Robin;
Venuto, Rocco C.

Publication type:

Article

The effects of alcohol on the pharmacokinetics and pharmacodynamics of the selective mu-opioid receptor antagonist GSK1521498 in healthy subjects.

Published in:

Journal of Clinical Pharmacology, 2013, v. 53, n. 10, p. 1078, doi. 10.1002/jcph.110

By:

Ziauddeen, Hisham;
Nathan, Pradeep J.;
Dodds, Chris;
Maltby, Kay;
Miller, Sam R.;
Waterworth, Dawn;
Song, Kijoung;
Warren, Liling;
Hosking, Louise;
Zucchetto, Mauro;
Bush, Mark;
Johnson, Lakshmi Vasist;
Sarai, Bhopinder;
Mogg, Karin;
Bradley, Brendan P.;
Richards, Duncan B.;
Fletcher, Paul C.;
Bullmore, Edward T.

Publication type:

Article

Electroencephalogram effects of armodafinil: Comparison with behavioral alertness.

Published in:

Journal of Clinical Pharmacology, 2013, v. 53, n. 10, p. 1058, doi. 10.1002/jcph.143

By:

Conrado, Daniela J.;
Bewernitz, Michael;
Ding, Mingzhou;
Cibula, Jean;
Seubert, Christoph;
Sy, Sherwin K. B.;
Eisenschenk, Stephan;
Derendorf, Hartmut

Publication type:

Article

Causality of rhabdomyolysis and combined tetanus, diphtheria and acellular pertussis (Tdap) vaccine administration.

Published in:

2013

By:

Kulkarni, Hemant;
Lenzo, Nat;
McLean‐Tooke, Andrew

Publication type:

Case Study

Person-centric clinical trials: An opportunity for the good clinical practice (GCP)-practice-based research network.

Published in:

Journal of Clinical Pharmacology, 2013, v. 53, n. 10, p. 1091, doi. 10.1002/jcph.138

By:

Curro, Frederick A.;
Robbins, Dennis A.;
Millenson, Michael L.;
Fox, Chester H.;
Naftolin, Frederick

Publication type:

Article

Utilizing pharmacokinetics/pharmacodynamics modeling to simultaneously examine free CCL2, total CCL2 and carlumab (CNTO 888) concentration time data.

Published in:

Journal of Clinical Pharmacology, 2013, v. 53, n. 10, p. 1020, doi. 10.1002/jcph.140

By:

Fetterly, Gerald J.;
Aras, Urvi;
Meholick, Patricia D.;
Takimoto, Chris;
Seetharam, Shobha;
McIntosh, Thomas;
de Bono, Johann S.;
Sandhu, Shahneen K.;
Tolcher, Anthony;
Davis, Hugh M.;
Zhou, Honghui;
Puchalski, Thomas A.

Publication type:

Article

Meldonium decreases the diet-increased plasma levels of trimethylamine N-oxide, a metabolite associated with atherosclerosis.

Published in:

Journal of Clinical Pharmacology, 2013, v. 53, n. 10, p. 1095, doi. 10.1002/jcph.135

By:

Dambrova, Maija;
Skapare‐Makarova, Elina;
Konrade, Ilze;
Pugovics, Osvalds;
Grinberga, Solveiga;
Tirzite, Dace;
Petrovska, Ramona;
Kalvins, Ivars;
Liepins, Edgars

Publication type:

Article

Simvastatin therapy decreases MMP-9 levels in obese women.

Published in:

Journal of Clinical Pharmacology, 2013, v. 53, n. 10, p. 1072, doi. 10.1002/jcph.146

By:

Andrade, Vanessa Leite;
Valle, Izabella Batistelli do;
Sandrim, Valeria Cristina

Publication type:

Article

Issue Information.

Published in:: Journal of Clinical Pharmacology, 2013, v. 53, n. 10, p. 1005, doi. 10.1002/jcph.168
Publication type:: Article